NDTP.US NDT Pharmaceuticals Inc

Healthcare Biotechnology USA Stocks
0.1065 USD
Close of Nov 15, 2026
0.0150 2.10
Market cap
USD 21.0M
P/E
-
P/B
49.36x
ROE
-
Dividend yield
-
Fundamental score
-

Is NDTP.US undervalued?

Graham number

The Graham number of NDT Pharmaceuticals Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

NDT Pharmaceuticals Inc fundamental analysis

No fundamental analysis for NDT Pharmaceuticals Inc yet.

NDT Pharmaceuticals Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About NDT Pharmaceuticals Inc

NDT Pharmaceuticals Inc., a biotechnology company, focuses on developing various therapies for severe neurological disorders associated with traumatic brain Injury. The company is based in Tulsa, Oklahoma.

Full company profile